A Study of Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Participants and Their Infants
A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06928316
ClinicalTrials.gov Identifier (NCT): NCT04424316
Protocol ID: C3671008
Open Plain Language Summary Result:
Click here